A Disruptive Technology in the Making

Affiliations

¹ Department of Cardiovascular Medicine, Baylor College of Medicine, Temple Campus, Temple, Texas, USA.
² Department of Cardiovascular Medicine, Mount Sinai Morningside-West, New York, New York, USA.

Editorial

Vinh Nguyen et al. JACC Case Rep. 2024.

. 2024 Dec 4;29(23):102808.

doi: 10.1016/j.jaccas.2024.102808.

¹ Department of Cardiovascular Medicine, Baylor College of Medicine, Temple Campus, Temple, Texas, USA.
² Department of Cardiovascular Medicine, Mount Sinai Morningside-West, New York, New York, USA.

No abstract available

Keywords: cardiac MRI; cardiomyopathy; lipid storage disease.

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

1. Lang R.M., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39. - PubMed
1. Kim R.J., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002. - PubMed
1. Kim R.J., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–1453. - PubMed
1. Friedrich M.G., et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53:1475–1487. - PMC - PubMed
1. Anderson L.J., et al. Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–2179. - PubMed